9/11 responders with PTSD may show accelerated biological aging

Researchers studying World Trade Center responders say PTSD may be tied to molecular signs of faster biological aging nearly two decades after the Sept. 11 attacks.

A Stony Brook-led team reported in Nature Communications that blood samples from 393 responders showed differences between those diagnosed with PTSD and those without the condition. The samples were collected about 18 years after 9/11.

The study does not prove PTSD caused the changes. But it adds to evidence that trauma can leave physical as well as psychological effects that may matter for long-term health care.

What the study found

The researchers analyzed blood from 232 responders with PTSD and 161 without PTSD. They reported 114 proteins and 7 metabolites that differed between the two groups.

According to coverage of the study, those molecular differences were linked to pathways involving brain function, immunity, energy metabolism, cellular repair and protection against cellular damage.

The reporting also said the findings were associated with signs of accelerated biological aging and could point to higher chronic-disease risk involving organs such as the heart, lungs, kidneys and liver.

Why the timing matters

The blood draw happened roughly 18 years after the attacks, giving researchers a long look at the possible biological aftermath of trauma exposure in a group with unusually extensive follow-up.

That makes the result notable for both 9/11 responders and other trauma survivors, because it suggests PTSD may be reflected not only in symptoms and behavior but also in measurable changes in the body.

Benjamin Luft, a lead researcher on the work, described PTSD as a whole-body illness and urged integrated long-term mental and physical follow-up for trauma survivors.

Public-health significance

The findings may matter for chronic-disease surveillance in responders who were exposed to the World Trade Center site and have been monitored for years.

Researchers and clinicians have long known that PTSD can affect sleep, mood and memory. This study adds support for the idea that trauma may also influence biological processes connected to aging and organ health.

That does not mean the blood markers can diagnose future disease on their own. It does mean the study strengthens the case for viewing PTSD as a condition with physical consequences that deserve ongoing medical attention.

What remains unknown

The evidence is associative, not causal. A single blood draw cannot show how the molecular changes developed, whether they are reversible or whether they predict later illness.

The study also focused on one narrowly defined population of World Trade Center responders, which limits how far the findings can be generalized to other PTSD groups.

Researchers still want to know how these molecular patterns evolve over time, whether they track with later disease and whether treatment changes the biological profile.

For now, the paper adds a new piece to a long-running effort to understand the physical costs of trauma exposure and the need for long-term surveillance in responders and other survivors.